| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |